| Recruitment status | Completed |
| Unique ID issued by UMIN | UMIN000040370 |
| Receipt No. | R000046072 |
| Scientific Title | Study on the influence of on time-dependent change of blood glucose level by palm sugar and brown sugar, etc. intake. |
| Date of disclosure of the study information | 2020/05/11 |
| Last modified on | 2020/11/10 (Ver. 3) |
| Basic information | ||
| Public title | Study on the influence of on time-dependent change of blood glucose level by palm sugar and brown sugar, etc. intake. | |
| Acronym | Study on the influence of on time-dependent change of blood glucose level by palm sugar and brown sugar, etc. intake. | |
| Scientific Title | Study on the influence of on time-dependent change of blood glucose level by palm sugar and brown sugar, etc. intake. | |
| Scientific Title:Acronym | Study on the influence of on time-dependent change of blood glucose level by palm sugar and brown sugar, etc. intake. | |
| Region |
|
|
| Condition | ||
| Condition | Healthy Adults | |
| Classification by specialty |
|
|
| Classification by malignancy | Others | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | Evaluate the time-dependent change of blood glucose level caused by intaking palm sugar and brown sugar, etc |
| Basic objectives2 | Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | Time course of blood glucose concentration changes before and after a single ingesting (delta AUC, delta Cmax, delta C, Tmax)
Measure at before ingestion and 15, 30, 45, 60, 90, and 120 minutes after ingestion. |
| Key secondary outcomes | none |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Cross-over |
| Randomization | Randomized |
| Randomization unit | Individual |
| Blinding | Open -no one is blinded |
| Control | Active |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | ||
| No. of arms | 4 | |
| Purpose of intervention | Prevention | |
| Type of intervention |
|
|
| Interventions/Control_1 | Intake of palm sugar 52.8g
Washout for 1day or more Intake of brown sugar 53.9g Washout for 1day or more Intake of white sugar 50.4g Washout for 1day or more Intake of glucose 50.0g |
|
| Interventions/Control_2 | Intake of brown sugar 53.9g
Washout for 1day or more Intake of white sugar 50.4g Washout for 1day or more Intake of glucose 50.0g Washout for 1day or more Intake of palm sugar 52.8g |
|
| Interventions/Control_3 | Intake of white sugar 50.4g
Washout for 1day or more Intake of glucose 50.0g Washout for 1day or more Intake of palm sugar 52.8g Washout for 1day or more Intake of brown sugar 53.9g |
|
| Interventions/Control_4 | Intake of glucose 50.0g
Washout for 1day or more Intake of palm sugar 52.8g Washout for 1day or more Intake of brown sugar 53.9g Washout for 1day or more Intake of white sugar 50.4g |
|
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | 1.Persons who received a sufficient explanation of the purpose and contents of the exam, have the capacity to consent, applied with free will with sufficient understanding, and agreed to participate with a written document
2.Healthy Japanese who are 20 years old or more and 50 years old or less 3.Persons whose BMI is 30.0 or less 4.Persons who do not have impaired glucose tolerance in the past year examination (As a result of medical checkup, persons with a fasting blood glucose of less than 110 mg / dL and HbA1c of less than 5.6%) 5.Persons who are not taking drugs such as anti-hypertensive agents |
|||
| Key exclusion criteria | 1.Persons who have chronic illness, receiving medication, have a serious disease history
2.Persons who are allergic to the test food 3.Persons who usually take a large amount of test food 4.Persons who usually take medicine, specified health food, healthy food 5.Persons who participated in other examination during the first month before the start of the exam, or those who plan to participate in other exams following this exam agreement 6.Persons who are judged inappropriate for the exam by the principal investigator 7.Persons who are breastfeeding, pregnant, scheduled or hoping to be pregnant during the exam period 8.Persons who may become menstrual period during the test period |
|||
| Target sample size | 10 | |||
| Research contact person | |||||||
| Name of lead principal investigator |
|
||||||
| Organization | Healthcare Systems Co., Ltd. | ||||||
| Division name | Research and Development Department | ||||||
| Zip code | 105-0004 | ||||||
| Address | Nisshin Tatemono Shinbashi Bld. 7F, 4-6-15 Shinbashi, Minato-ku, Tokyo, JAPAN | ||||||
| TEL | 03-6809-2722 | ||||||
| ishikawa@hc-sys.jp | |||||||
| Public contact | |||||||
| Name of contact person |
|
||||||
| Organization | Healthcare Systems Co., Ltd. | ||||||
| Division name | Sales Planning Department | ||||||
| Zip code | 105-0004 | ||||||
| Address | Nisshin Tatemono Shinbashi Bld. 7F, 4-6-15 Shinbashi, Minato-ku, Tokyo, JAPAN | ||||||
| TEL | 070-1450-5470 | ||||||
| Homepage URL | |||||||
| kobayashi@hc-sys.jp | |||||||
| Sponsor | |
| Institute | Healthcare Systems Co., Ltd. |
| Institute | |
| Department | |
| Funding Source | |
| Organization | KANERYO Sea Vegetable Corporation |
| Organization | |
| Division | |
| Category of Funding Organization | Profit organization |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| IRB Contact (For public release) | |
| Organization | The Ethics Committee of Healthcare Systems Co., Ltd. |
| Address | Nisshin Tatemono Shinbashi Bld. 7F, 4-6-15 Shinbashi, Minato-ku, Tokyo, JAPAN |
| Tel | 03-6809-2722 |
| soumu@hc-sys.jp | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| Result | |
| URL related to results and publications | |
| Number of participants that the trial has enrolled | 10 |
| Results | |
| Results date posted | |
| Results Delayed | |
| Results Delay Reason | |
| Date of the first journal publication of results | |
| Baseline Characteristics | |
| Participant flow | |
| Adverse events | |
| Outcome measures | |
| Plan to share IPD | |
| IPD sharing Plan description | |
| Progress | |||||||
| Recruitment status | Completed | ||||||
| Date of protocol fixation |
|
||||||
| Date of IRB |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Other | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000046072 |